Compare MYPS & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MYPS | BHST |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.4M | 137.1M |
| IPO Year | N/A | N/A |
| Metric | MYPS | BHST |
|---|---|---|
| Price | $0.63 | $5.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $2.00 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 194.2K | 59.1K |
| Earning Date | 11-03-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $247,477,000.00 | $32,720,000.00 |
| Revenue This Year | N/A | $116.40 |
| Revenue Next Year | N/A | $55.91 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 45.88 |
| 52 Week Low | $0.57 | $4.72 |
| 52 Week High | $1.99 | $12.80 |
| Indicator | MYPS | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 45.34 |
| Support Level | $0.64 | $5.08 |
| Resistance Level | $0.66 | $5.43 |
| Average True Range (ATR) | 0.03 | 0.37 |
| MACD | 0.00 | 0.11 |
| Stochastic Oscillator | 12.20 | 68.57 |
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.